Single-cell and spatial transcriptomics resolve airway obliteration in bronchiolitis obliterans syndrome
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Chronic lung allograft dysfunction (CLAD) is the leading cause of death beyond the first year after lung transplantation, and its most frequent phenotype is bronchiolitis obliterans syndrome (BOS), a fibrotic small-airway disease. Mechanistic work has focused on the immune compartment, yet intensified immunosuppression does not alter established disease. Aim To resolve which structural cell states populate the BOS graft and how they are spatially organized during airway obliteration. Methods We profiled explanted lungs from 33 BOS patients undergoing re-transplantation and 33 controls, combining single-nucleus RNA sequencing (14 BOS, 13 controls) with targeted spatial transcriptomics of 108 regions (27 BOS, 24 controls) and multiplex immunofluorescence validation. Single-nucleus data were integrated with a published restrictive allograft syndrome (RAS) atlas. Results Across 175,128 nuclei and 1.67 million spatially resolved cells, BOS lungs harbored a profibrotic circuit of Aberrant Basaloid cells and CTHRC1 + fibrotic fibroblasts previously described in fibrotic lung diseases, including RAS. Spatial mapping identified a CXCL14 + TNC + injury-associated basal cell state arising early in the obliterative cascade, identifying basal cells as their major reservoir. CTHRC1 + fibroblasts expanded subepithelially replacing resident peribronchial fibroblasts, alongside a peribronchial vascular shift toward systemic venous endothelium. The circuit extended beyond the airway wall to the alveolar interface, defining two convergent remodeling fronts. Conclusion BOS engages structural-cell circuits largely shared with RAS and fibrotic lung diseases, but along an airway-centered rather than parenchyma-centered axis. CLAD thus emerges as a spatial rather than cellular spectrum, defined by anatomical distribution more than cell identity. Shared structural programs may therefore be targetable across CLAD phenotypes.
Authors: Jannik Ruwisch, Hande Yilmaz, Leonard Christian, Lavinia Neubert, Lena M. Leiber, Annalea Brüggemann, Sneha Banerjee, Mark Greer, Wiebke Rackwitz, Leon Giercke, Christopher Werlein, Carina A Pawlow, Regina Engelhardt, Axelle Coppens, Matthias Ballmaier, Evgeny Chichelnitskiy, Susanne Simon, Jawad Salman, Khalil Aburahma, Ali Önder Yildirim, Janine Gote-Schniering, Jens Hohlfeld, Bard Vanaudenaerde, Danny D. Jonigk, Sabine Dettmer, Fabio Ius, Marius M Hoeper, Svenja Gaedcke, Naftali Kaminski, Yang Li, Stijn E Verleden, Jens Gottlieb, Christine Falk, Jan C. Kamp, Jonas C. Schupp
Institutions: Medizinische Hochschule Hannover, German Center for Lung Research, University of Antwerp, Antwerp University Hospital, Helmholtz Munich, University of Bern, University Hospital of Bern, Fraunhofer Institute for Toxicology and Experimental Medicine, KU Leuven, RWTH Aachen University, Yale University, Radboud University Nijmegen, Radboud University Medical Center, Centre for Individualised Infection Medicine, Center for Experimental and Clinical Infection Research, CAIMed - Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204149689
